Kimberly Chong

Array ( [id] => 6600417 [patent_doc_number] => 20100292301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'NOVEL SIRNA STRUCTURES' [patent_app_type] => utility [patent_app_number] => 12/528907 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12933 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292301.pdf [firstpage_image] =>[orig_patent_app_number] => 12528907 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6245970 [patent_doc_number] => 20100136092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'TRANSDERMAL IMMUNE PREPARATION, METHOD FOR PRODUCTION OF THE SAME, AND TRANSDERMAL IMMUNIZATION METHOD USING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/529200 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5894 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136092.pdf [firstpage_image] =>[orig_patent_app_number] => 12529200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727945 [patent_doc_number] => 20080207489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Use of CCN5 for treatment of smooth muscle proliferation disorders' [patent_app_type] => utility [patent_app_number] => 12/070814 [patent_app_country] => US [patent_app_date] => 2008-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 29113 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207489.pdf [firstpage_image] =>[orig_patent_app_number] => 12070814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363462 [patent_doc_number] => 08252527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Method for identification of polynucleotides capable of cleaving target mRNA sequences' [patent_app_type] => utility [patent_app_number] => 12/070561 [patent_app_country] => US [patent_app_date] => 2008-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 9380 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12070561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6441691 [patent_doc_number] => 20100104584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'GENES INVOLVED IN MITOCHONDRIAL BIOGENESIS' [patent_app_type] => utility [patent_app_number] => 12/526674 [patent_app_country] => US [patent_app_date] => 2008-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 22769 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20100104584.pdf [firstpage_image] =>[orig_patent_app_number] => 12526674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10628914 [patent_doc_number] => 09347060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Biologically active molecules, particularly based on PNA and siRNA, method for the cell-specific activation thereof, and application kit to be administered' [patent_app_type] => utility [patent_app_number] => 12/449419 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3516 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12449419 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174116 [patent_doc_number] => 20110177038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'Inhibition of Tumor Growth via Peroxiredoxin 3' [patent_app_type] => utility [patent_app_number] => 12/028441 [patent_app_country] => US [patent_app_date] => 2008-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7978 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20110177038.pdf [firstpage_image] =>[orig_patent_app_number] => 12028441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228958 [patent_doc_number] => 20100183696 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists' [patent_app_type] => utility [patent_app_number] => 12/524217 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 22618 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183696.pdf [firstpage_image] =>[orig_patent_app_number] => 12524217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8846009 [patent_doc_number] => 08455188 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-04 [patent_title] => 'Modification of exosomal components for use as a vaccine' [patent_app_type] => utility [patent_app_number] => 12/524432 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11688 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12524432 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8115121 [patent_doc_number] => 08158773 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-17 [patent_title] => 'RNAi modulation of RSV and therapeutic uses thereof' [patent_app_type] => utility [patent_app_number] => 12/021245 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 17469 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/158/08158773.pdf [firstpage_image] =>[orig_patent_app_number] => 12021245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6267731 [patent_doc_number] => 20100298407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'COMPOSITIONS AND METHODS FEATURING MICRONAS FOR TREATING NEOPLASIA' [patent_app_type] => utility [patent_app_number] => 12/523431 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 60 [patent_no_of_words] => 28470 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298407.pdf [firstpage_image] =>[orig_patent_app_number] => 12523431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480164 [patent_doc_number] => 20090203121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'NUCLEIC ACID AGENTS FOR DOWNREGULATING H19, AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/015325 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19028 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203121.pdf [firstpage_image] =>[orig_patent_app_number] => 12015325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6353055 [patent_doc_number] => 20100086526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'NUCLEIC ACID CONSTRUCTS AND METHODS FOR SPECIFIC SILENCING OF H19' [patent_app_type] => utility [patent_app_number] => 12/523298 [patent_app_country] => US [patent_app_date] => 2008-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16547 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086526.pdf [firstpage_image] =>[orig_patent_app_number] => 12523298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7762806 [patent_doc_number] => 08114982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-02-14 [patent_title] => 'Multi-microRNA methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/312616 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9563 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 190 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/114/08114982.pdf [firstpage_image] =>[orig_patent_app_number] => 12312616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600418 [patent_doc_number] => 20100098664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression' [patent_app_type] => utility [patent_app_number] => 11/987267 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11911 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20100098664.pdf [firstpage_image] =>[orig_patent_app_number] => 11987267 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4921990 [patent_doc_number] => 20080070305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'INHIBITION OF EXPRESSION OF A TARGET GENE' [patent_app_type] => utility [patent_app_number] => 11/941224 [patent_app_country] => US [patent_app_date] => 2007-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4686 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0070/20080070305.pdf [firstpage_image] =>[orig_patent_app_number] => 11941224 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6271462 [patent_doc_number] => 20100255112 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'Efficient Nuclear Delivery of Antisense Oligonucleotides or siRNA In Vitro and In Vivo by Nano-Transforming Polymersomes' [patent_app_type] => utility [patent_app_number] => 12/514784 [patent_app_country] => US [patent_app_date] => 2007-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 7222 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20100255112.pdf [firstpage_image] =>[orig_patent_app_number] => 12514784 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682338 [patent_doc_number] => 20080248564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'NOVEL PROPERTY EFFECTING AND/OR PROPERTY EXHIBITING COMPOSITIONS FOR THERAPEUTIC AND DIAGNOSTIC USES' [patent_app_type] => utility [patent_app_number] => 11/929897 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 39395 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248564.pdf [firstpage_image] =>[orig_patent_app_number] => 11929897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6525760 [patent_doc_number] => 20100203513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'MICRORNA AS BIOMARKER IN CANCER' [patent_app_type] => utility [patent_app_number] => 12/513007 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 8253 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20100203513.pdf [firstpage_image] =>[orig_patent_app_number] => 12513007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4903963 [patent_doc_number] => 20080113376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-15 [patent_title] => 'siRNA targeting myeloid differentiation primary response gene (88) (MYD88)' [patent_app_type] => utility [patent_app_number] => 11/980102 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34306 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20080113376.pdf [firstpage_image] =>[orig_patent_app_number] => 11980102 [rel_patent_id] =>[rel_patent_doc_number] =>)